# Gambling Harms Research Grants **Funder:** AHRC (UKRI) **Budget:** Up to £2,000,000 FEC (80% funded by UKRI) **Duration:** 3 years **Application:** Expression of Interest (by 17 July 2026) → Full application (opens 21 September 2026) **Frequency:** One-off **Eligible countries:** GB **Official call:** https://www.ukri.org/opportunity/gambling-harms-research-grants/ **Last verified:** 4 July 2026 ## Eligibility & scope Open to UK research institutions eligible for UKRI funding (HEPs, IROs, PSREs, NHS bodies) as project lead. Interdisciplinary/multidisciplinary teams required, including people with lived experience of gambling harms. Non-standard eligibility organisations (charities, businesses, international) may co-lead; combined non-standard costs capped at 30% FEC. Gambling industry licence holders subject to the levy cannot host or receive funds. PhD studentships not eligible. ## Summary The UKRI Gambling Harms Research Grants fund up to £2,000,000 over three years for interdisciplinary research teams tackling gambling harms and addiction. Teams must include people with lived experience of gambling harms and be led by a UK research institution eligible for UKRI funding; charities, businesses, and international organisations may co-lead but cannot exceed 30% of project costs. This is a one-off call closing to Expression of Interest on 17 July 2026, with full applications opening in September 2026. ## Who should apply - Lead researchers at UK research institutions (universities, independent research organisations, public-sector research establishments, NHS bodies) - Interdisciplinary teams combining academic expertise with people with lived experience of gambling harms - Projects bridging public health, psychology, social sciences, economics, or related disciplines - Teams willing to include community and third-sector partners (charities, lived-experience networks) - Applicants whose organisations are not under gambling industry levy restrictions ## Key dates - Expression of Interest deadline: 17 July 2026 - Full application window opens: 21 September 2026 (date for second deadline not stated in metadata) - Three-year project duration - Awards expected: July 2027 ## Tips for applicants - Lived experience is mandatory, not optional, embed people with gambling harms expertise as named investigators, not token advisors. - Interdisciplinarity is assessed; justify why your disciplinary mix is essential to the research question. - Non-standard partner costs (charities, businesses, international) cannot exceed 30% of the total FEC, plan your budget structure upfront to avoid triage rejection. ## Frequently asked questions ### Who can be the lead organisation for UKRI Gambling Harms Research Grants? A UK research institution eligible for UKRI funding: a higher education institution, independent research organisation, public-sector research establishment, or NHS body. Charities and businesses may co-lead but cannot be the project lead, and their combined costs are capped at 30% of the full economic cost. ### Do I need people with lived experience on my team? Yes, teams must include people with lived experience of gambling harms as part of the project team, not just as external advisors. ### How much is the UKRI Gambling Harms Research Grant? Up to £2,000,000 full economic cost (FEC), with 80% funded by UKRI; the remaining 20% must be found by the applicant or project partners. ### What is the deadline for UKRI Gambling Harms Research Grants? Expression of Interest closes 17 July 2026; full applications open 21 September 2026, with awards expected in July 2027. ### Is this a recurring grant opportunity? No, this is a one-off call; there is no stated plan for future rounds. --- Source: [The Great Grantsby](https://grantsby.eu/grants/ukri-delivered-by-ahrc-gambling-harms-research-grants-2026) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying. **See which EU calls match your profile.** [Preview your matches in 30 seconds, no signup](https://grantsby.eu/demo?ref=llm_grant_md).